+91 96866 96505
/
080 222 400 34
info@oncostemdiagnostics.com
About Us
Leadership
Advisors
Awards and Recognition
CanAssist Breast
About CanAssist Breast
Science and Validation
How it works
Sample Report
Understand your risk score
Testimonials
FAQs
Media
Media Mentions
Videos
Newsletter
Resources
Brochures
Scientific Publications
Testimonials
Contact Us
Contact Us
Careers
OncoStem
CanAssist Breast
Resources
Scientific Publications
Know More
Scientific Publications and International Conference Presentations by
OncoStem Team
Comparison of Risk Stratification by CanAssist Breast Test Performed on Core Needle Biopsies Versus Surgical Specimens in Hormone Receptor-Positive, Her2-Negative Early Breast Cancer
ESMO Congress 2024 - European Society for Medical Oncology: Real-world data on prognostication of early-stage breast cancer patients using CanAssist Breast
The usefulness of CanAssist Breast over Ki67 in breast cancer recurrence risk assessment
Ten-year distant-recurrence risk prediction in breast cancer by CanAssist Breast (CAB) in Dutch sub-cohort of the randomized TEAM trial
A comparative analysis of recurrence risk predictions in ER+/HER2−early breast cancer using NHS Nottingham Prognostic Index, PREDICT, and CanAssist Breast
A retrospective validation of CanAssist Breast in European early-stage breast cancer patient cohort
9P-Long term recurrence risk predictions by CanAssist Breast in a sub-cohort of TEAM
Validation of CanAssist Breast immunohistochemistry biomarkers on an automated platform and its applicability in tissue microarray
Multi-country clinical validation of CanAssist Breast in Europe indicates robustness of the test
Comparison of breast cancer prognostic tests CanAssist Breast and Oncotype DX
Canassist breast: An affordable breast cancer prognostic test validated on Asian patients
CanAssist Breast Impacting Clinical Treatment Decisions in Early-Stage HR+ Breast Cancer Patients: Indian Scenario
Clinical validation of CanAssist breast in a Spanish cohort
Impact of CanAssist-Breast in clinical treatment decisions in early stage HR+ breast cancer patients: Asian Scenario
Clinical validation of an immunohistochemistry-based CanAssist-Breast test for distant recurrence prediction in hormone receptor-positive breast cancer patients
Analytical validation of CanAssist-Breast: an immunohistochemistry based prognostic test for hormone receptor positive breast cancer patients
Development of a Novel Proteomic Risk-Classifier for Prognostication of Patients With Early-Stage Hormone Receptor–Positive Breast Cancer
Risk stratification in early-stage estrogen receptor+/HER2-breast cancer patients: Comparative analysis of cost-effective methods
CanAssist-Breast -an immunohistochemistry based test for risk of recurrence prediction for early stage breast cancer patients: A cost-effective and accurate solution for Asia
Risk of recurrence prediction and optimum treatment planning for early stage breast cancer patients: A cost-effective, accurate and broad based solution for Asia
Assessment of Ki67 As a Prognostic Marker in Hormone Receptor Positive Breast Cancer: A Retrospective Study on An Indian Cohort
Androgen Receptor mRNA levels determine the prognosis in triple-negative breast cancer patients
Scientific Publications and International Conference Presentations by renowned Indian oncologists
Somashekhar S P et al
San Antonio Breast Cancer Symposium (SABCS) 2024: Real world data on prognostication in India using CanAssist Breast- an indigenous test validated in global studies.
Purvish Parikh et al
Ajay Bapna et al
Ashok Vaid et al
Purvish Parikh et al
Purvish Parikh et al
Arvind Krishnamurthy
Gouri Shankar Bhattacharyya et al
Presentation at various prestigious events & conferences
Oct 2024: Dr. Manjiri Bakre was delighted to present real-world data on CanAssist Breast at the Breastanbul 2024 Conference, sharing key insights with global experts.
December 2023 : Talk given by Dr. Manjiri Bakre on ‘Does every breast cancer patient need chemotherapy? And Role of “Made in India” innovative tests in decision making’ to talented audience of Pathologists and Micrbiologists at GAPM 2023 in Vadodara
December 2023: Dr. Rohan Khandelwal shared groundbreaking insights about the CanAssist Breast Test at OFCON Conference, New Delhi
November 2023 : Talk given by Dr. Mandeep Singh at ASOMACON, Dehradun
November 2023 : Presented an Advisory about the CAB test at ICC, Mumbai
October 2023 : Dr. D. G. Vijay explained data on CanAssist Breast in a CME at Udaipur, Rajasthan
October 2023 : Talk given by Dr. D. G. Vijay at Association of Surgeons of India (ASICON)
July 2023: Advisory & conference talks given by Dr. Manjiri Bakre at ABSICON, (Association of Breast Surgeons of India) Ahmedabad
June 2023: Dr.Manjiri Bakre gave a talk on the CAB test at Acharya Harihar Post Graduate Institute of Cancer, Bhubaneswar
April 2023: Dr. Chirag Desai presented data on the CAB test at an advisory meeting in Ahmedabad
March 2023: Dr. S. P. Somashekar shared insights about the CAB test at ABSI Midcon 2023 which was held in Patna
February 2023: Dr. B. A. Savitha showcased the CAB test at 28th AIPNA - ICP International CME in pathology 2023
January 2023: Presented CAB test at The West Bengal Chapter of the Association of Surgeons of India
December 2022: CanAssist Breast advisory meeting in Kolkata
December 2022: CanAssist Breast advisory meeting in Delhi
Want to know about your recurrence risk?
to personalize your cancer treatment and reduce the risk & side effects of chemotheraphy
Know more
 2024.png)
